Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Monthly Communication Reports in: April 2024

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

The list below is sorted by communication date, beginning with the most recent.

GlaxoSmithKline

Sridhar Venkatesh, General Manager and President (Corporation)

Results 1-7 of 7

  • GlaxoSmithKline
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Economic Development, Health
    Communication date: 2024-04-30
    Posted date: 2024-05-15
    Communication number: 5088-601821 View associated registration
  • GlaxoSmithKline
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Semhar Zerat, Director | Programs and Partnerships Division | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2024-04-16
    Posted date: 2024-05-15
    Communication number: 5088-601822 View associated registration
  • GlaxoSmithKline
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Jaxson Khan, Sr Policy Advisor | MINISTER OF INNOVATION, SCIENCE AND INDUSTRY | Innovation, Science and Economic Development Canada (ISED)
    • Laurel Chester, Senior Advisor | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Economic Development, Government Procurement
    Communication date: 2024-04-16
    Posted date: 2024-05-15
    Communication number: 5088-600955 View associated registration
  • GlaxoSmithKline
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Colin Deacon, Senator | Senate of Canada

    Subject Matter of the communication: Economic Development
    Communication date: 2024-04-16
    Posted date: 2024-05-15
    Communication number: 5088-600954 View associated registration
  • GlaxoSmithKline
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Francis Bilodeau, Associate Deputy Minister | Office of the Associate Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Andrea Johnston, Assistant deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Etienne-Rene Massie, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Economic Development, Research and Development
    Communication date: 2024-04-15
    Posted date: 2024-05-15
    Communication number: 5088-600953 View associated registration
  • GlaxoSmithKline
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Mark Schaan, Senior Assistant Deputy Minister | Strategy and Innovation Policy Sector - Assistant Deputy Minister's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Economic Development, Research and Development
    Communication date: 2024-04-15
    Posted date: 2024-05-15
    Communication number: 5088-600952 View associated registration
  • GlaxoSmithKline
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Joel Denis, Director General | Centre for Vaccine and Therapeutics Readiness | Public Health Agency of Canada (PHAC)

    Subject Matter of the communication: Health
    Communication date: 2024-04-04
    Posted date: 2024-05-15
    Communication number: 5088-599236 View associated registration

Return to Monthly Communication Reports by Reporting Period

Date Modified: